Novo Nordisk A/S (NOVO-B.CO)
Novo Nordisk A/S last traded at 260.45 DKK. Over the past month the price moved +2.94%. Historical scenarios, expert targets and the plain-language read from AIsier.
One-year price chart
Last price
260.45 DKK
- 1 week
- +1.54%
- 1 month
- +2.94%
- 3 months
- -21.36%
- 1 year
- -19.75%
- 52-week high
- 383.09 DKK
- 52-week low
- 220.97 DKK
Stocks
- Symbol
- NOVO-B.CO
- Currency
- DKK
- Sector
- Healthcare
- Market value (USD)
- 172,040,624,926 USD ()
AIsier's plain-language read
Novo Nordisk's price has dropped roughly 7% over the past month, sitting well below where it traded on average over the last few months.
What is going on right now?
The stock has drifted lower recently, losing about 7% in 30 days. It now trades noticeably below its prices from the past couple of months.
How is the business itself doing?
Novo Nordisk makes obesity and diabetes treatments, plus medicines for rare diseases. Revenue grew about 2%, but earnings fell roughly 21% last quarter. The company still keeps about 35 cents of every dollar it earns as profit.
What stands out?
Reports about new melanoma and ovarian cancer trial data across the broader pharmaceutical space may affect sentiment around drug companies generally, including Novo Nordisk.
What comes next?
Novo Nordisk's next earnings report is scheduled for November 4, 2026, and it will show whether that earnings drop continued or reversed.
FAQ
What is the current price of Novo Nordisk A/S?
As of Oct. 26, 2026, the latest recorded price of Novo Nordisk A/S (NOVO-B.CO) was 260.45 DKK.
How has Novo Nordisk A/S moved recently?
Measured from closing prices: +1.54% over one week, +2.94% over one month and -19.75% over one year.
